Temporal memory deficits in Alzheimer's mouse models: Rescue by genetic deletion of BACE1

European Journal of Neuroscience

Volumn 23, Issue 1, 2006, Pages 251-260

  Ohno, Masuo ^a   Chang, Lei ^b   Tseng, Wilbur ^a   Oakley, Holly ^a   Citron, Martin ^c   Klein, William L ^b   Vassar, Robert ^a   Disterhoft, John F ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c AMGEN INC   (United States)

Author keywords

secretase; Alzheimer's disease; Amyloid oligomers; APP PS1 transgenic mouse; Trace fear conditioning

Indexed keywords

AMYLOID PRECURSOR PROTEIN; BETA SECRETASE; OLIGOMER; PRESENILIN 1;

ALZHEIMER DISEASE; AMNESIA; ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASSAY; BEHAVIOR; BRAIN FUNCTION; COGNITIVE DEFECT; COMPARATIVE STUDY; CONTROLLED STUDY; FEAR; GENE DELETION; HIPPOCAMPUS; MEMORY; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID PRECURSOR PROTEIN SECRETASES; ANALYSIS OF VARIANCE; ANIMALS; ASPARTIC ENDOPEPTIDASES; BLOTTING, WESTERN; CONDITIONING (PSYCHOLOGY); DISEASE MODELS, ANIMAL; ENDOPEPTIDASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEAR; IMMUNOBLOTTING; MAZE LEARNING; MEMBRANE PROTEINS; MEMORY DISORDERS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PRESENILIN-1;

EID: 33644957833     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2005.04551.x     Document Type: Article

References (62)

1. Ashe KH. 2001 Learning and memory in transgenic mice modeling Alzheimer's disease LearnMem 8 301 308
2. Borchelt DR. Ratovitski T. van Lare J. Lee MK. Gonzales V. Jenkins NA. Copeland NG. Price DL. Sisodia SS. 1997 Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins Neuron 19 939 945
3. Bourtchuladze R. Frenguelli B. Blendy J. Cioffi D. Schutz G. Silva AJ. 1994 Deficient long-term memory in mice with a targeted mutation of the cAMP-responsive element-binding protein Cell 79 59 68
4. Chang L. Bakhos L. Wang Z. Venton DL. Klein WL. 2003 Femtomole immunodetection of synthetic and endogenous amyloid-β oligomers and its application to Alzheimer's disease drug candidate screening JMolNeurosci 20 305 313
5. Choi SH. Park CH. Koo JW. Seo JH. Kim HS. Jeong SJ. Lee JH. Kim SS. Suh YH. 2001 Memory impairment and cholinergic dysfunction by centrally administered Aβ and carboxyl-terminal fragment of Alzheimer's APP in mice FASEB J 15 1816 1818
6. Cleary JP. Walsh DM. Hofmeister JJ. Shankar GM. Kuskowski MA. Selkoe DJ. Ashe KH. 2005 Natural oligomers of the amyloid-β protein specifically disrupt cognitive function NatNeurosci 8 79 84
7. Corcoran KA. Lu Y. Turner RS. Maren S. 2002 Overexpression of hAPPswe impairs rewarded alternation and contextual fear conditioning in a transgenic mouse model of Alzheimer's disease LearnMem 9 243 252
8. Dewachter I. Reverse D. Caluwaerts N. Ris L. Kuiperi C. Van Den Haute C. Spittaels K. Umans L. Serneels L. Thiry E. Moechars D. Mercken M. Godaux E. Van Leuven F. 2002 Neuronal deficiency of presenilin 1 inhibits amyloid plaque formation and corrects hippocampal long-term potentiation but not a cognitive defect of amyloid precursor protein [V717I] transgenic mice JNeurosci 22 3445 3453
9. Dineley KT. Xia X. Bui D. Sweatt JD. Zheng H. 2002 Accelerated plaque accumulation, associative learning deficits, and up-regulation of α7 nicotinic receptor protein in transgenic mice co-expressing mutant human presenilin 1 and amyloid precursor proteins JBiolChem 277 22768 22780
10. Dodart JC. Bales KR. Gannon KS. Greene SJ. DeMattos RB. Mathis C. DeLong CA. Wu S. Wu X. Holtzman DM. Paul SM. 2002 Immunization reverses memory deficits without reducing brain Aβ burden in Alzheimer's disease model NatNeurosci 5 452 457
11. Georganopoulou DG. Chang L. Nam JM. Thaxton CS. Mufson EJ. Klein WL. Mirkin CA. 2005 Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer's disease ProcNatlAcadSciUSA 102 2273 2276
12. German DC. Eisch AJ. 2004 Mouse models of Alzheimer's disease: insight into treatment RevNeurosci 15 353 369
13. Gong Y. Chang L. Viola KL. Lacor PN. Lambert MP. Finch CE. Krafft GA. Klein WL. 2003 Alzheimer's disease-affected brain: presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss ProcNatlAcadSciUSA 100 10417 10422
14. Haass C. Schlossmacher MG. Hung AY. Vigo-Pelfrey C. Mellon A. Ostaszewski BL. Lieberburg I. Koo EH. Schenk D. Teplow DB. Selkoe DJ. 1992 Amyloid β-peptide is produced by cultured cells during normal metabolism Nature 359 322 325
15. Hardy J. Selkoe DJ. 2002 The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics Science 297 353 356
16. Holcomb L. Gordon MN. McGowan E. Yu X. Benkovic S. Jantzen P. Wright K. Saad I. Mueller R. Morgan D. Sanders S. Zehr C. O'Campo K. Hardy J. Prada CM. Eckman C. Younkin S. Hsiao K. Duff K. 1998 Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes NatMed 4 97 100
17. Hsia AY. Masliah E. McConlogue L. Yu GQ. Tatsuno G. Hu K. Kholodenko D. Malenka RC. Nicoll RA. Mucke L. 1999 Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models ProcNatlAcadSciUSA 96 3228 3233
18. Hsiao K. Chapman P. Nilsen S. Eckman C. Harigaya Y. Younkin S. Yang F. Cole G. 1996 Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice Science 274 99 102
19. Huerta P. Sun L. Wilson M. Tonegawa S. 2000 Formation of temporal memory requires NMDA receptors within CA1 pyramidal neurons Neuron 25 473 480
20. Janus C. Westaway D. 2001 Transgenic mouse models of Alzheimer's disease PhysiolBehav 73 873 886
21. John V. Beck JP. Bienkowski MJ. Sinha S. Heinrikson RL. 2003 Human β-secretase (BACE) and BACE inhibitors JMedChem 46 4625 4630
22. Kamenetz F. Tomita T. Hsieh H. Seabrook G. Borchelt D. Iwatsubo T. Sisodia S. Malinow R. 2003 APP processing and synaptic function Neuron 37 925 937
23. Katzman R. Terry R. DeTeresa R. Brown T. Davies P. Fuld P. Renbing X. Peck A. 1988 Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques AnnNeurol 23 138 144
24. Kawarabayashi T. Younkin LH. Saido TC. Shoji M. Ashe KH. Younkin SG. 2001 Age-dependent changes in brain, CSF, and plasma amyloid β protein in the Tg2576 transgenic mouse model of Alzheimer's disease JNeurosci 21 372 381
25. Kayed R. Head E. Thompson JL. McIntire TM. Milton SC. Cotman CW. Glabe CG. 2003 Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis Science 300 486 489
26. Kitazume S. Tachida Y. Oka R. Shirotani K. Saido TC. Hashimoto Y. 2001 Alzheimer's β-secretase, β-site amyloid precursor protein-cleaving enzyme, is responsible for cleavage secretion of a Golgi-resident sialyltransferase ProcNatlAcadSciUSA 98 13554 13559
27. Klein W. Krafft G. Finch C. 2001 Targeting small Aβ oligomers: the solution to an Alzheimer's disease conundrum? Trends Neurosci 24 219 224
28. Klein WL. Stine WB. Jr. Teplow DB. 2004 Small assemblies of unmodified amyloid β-protein are the proximate neurotoxin in Alzheimer's disease NeurobiolAging 25 569 580
29. Klyubin I. Walsh DM. Lemere CA. Cullen WK. Shankar GM. Betts V. Spooner ET. Jiang L. Anwyl R. Selkoe DJ. Rowan MJ. 2005 Amyloid β protein immunotherapy neutralizes Aβ oligomers that disrupt synaptic plasticity in vivo NatMed 11 556 561
30. Kobayashi DT. Chen KS. 2005 Behavioral phenotypes of amyloid-based genetically modified mouse models of Alzheimer's disease Genes Brain Behav 4 173 196
31. Lacor PN. Buniel MC. Chang L. Fernandez SJ. Gong Y. Viola KL. Lambert MP. Velasco PT. Bigio EH. Finch CE. Krafft GA. Klein WL. 2004 Synaptic targeting by Alzheimer's-related amyloid β oligomers JNeurosci 24 10191 10200
32. LaFerla FM. Oddo S. 2005 Alzheimer's disease: Aβ, tau and synaptic dysfunction Trends MolMed 11 170 176
33. Lambert MP. Barlow AK. Chromy BA. Edwards C. Freed R. Liosatos M. Morgan TE. Rozovsky I. Trommer B. Viola KL. Wals P. Zhang C. Finch CE. Krafft GA. Klein WL. 1998 Diffusible, nonfibrillar ligands derived from Aβ1-42 are potent central nervous system neurotoxins ProcNatlAcadSciUSA 95 6448 6453
34. Lambert MP. Viola KL. Chromy BA. Chang L. Morgan TE. Yu J. Venton DL. Krafft GA. Finch CE. Klein WL. 2001 Vaccination with soluble Aβ oligomers generates toxicity-neutralizing antibodies JNeurochem 79 595 605
35. Lichtenthaler SF. Dominguez DI. Westmeyer GG. Reiss K. Haass C. Saftig P. De Strooper B. Seed B. 2003 The cell adhesion protein P-selectin glycoprotein ligand-1 is a substrate for the aspartyl protease BACE1 JBiolChem 278 48713 48719
36. Lue LF. Kuo YM. Roher AE. Brachova L. Shen Y. Sue L. Beach T. Kurth JH. Rydel RE. Rogers J. 1999 Soluble amyloid β peptide concentration as a predictor of synaptic change in Alzheimer's disease AmJPathol 155 853 862
37. Luo Y. Bolon B. Damore MA. Fitzpatrick D. Liu H. Zhang J. Yan Q. Vassar R. Citron M. 2003 BACE1 (β-secretase) knockout mice do not acquire compensatory gene expression changes or develop neural lesions over time NeurobiolDis 14 81 88
38. Luo Y. Bolon B. Kahn S. Bennett BD. Babu-Khan S. Denis P. Fan W. Kha H. Zhang J. Gong Y. Martin L. Louis JC. Yan Q. Richards WG. Citron M. Vassar R. 2001 Mice deficient in BACE1, the Alzheimer's β-secretase, have normal phenotype and abolished β-amyloid generation NatNeurosci 4 231 232
39. Mattson MP. 2004 Pathways towards and away from Alzheimer's disease Nature 430 631 639
40. McEchron MD. Bouwmeester H. Tseng W. Weiss C. Disterhoft JF. 1998 Hippocampectomy disrupts auditory trace fear conditioning and contextual fear conditioning in the rat Hippocampus 8 638 646
41. Meziane H. Dodart JC. Mathis C. Little S. Clemens J. Paul SM. Ungerer A. 1998 Memory-enhancing effects of secreted forms of the β-amyloid precursor protein in normal and amnestic mice ProcNatlAcadSciUSA 95 12683 12688
42. Misane I. Tovote P. Meyer M. Spiess J. Ogren SO. Stiedl O. 2005 Time-dependent involvement of the dorsal hippocampus in trace fear conditioning in mice Hippocampus 15 418 426
43. Morris RGM. Anderson E. Lynch GS. Baudry M. 1986 Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5 Nature 319 774 776
44. 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation JNeurosci 20 4050 4058
45. Nalbantoglu J. Tirado-Santiago G. Lahsaini A. Poirier J. Goncalves O. Verge G. Momoli F. Welner SA. Massicotte G. Julien JP. Shapiro ML. 1997 Impaired learning and LTP in mice expressing the carboxy terminus of the Alzheimer amyloid precursor protein Nature 387 500 505
46. Ohno M. Frankland PW. Chen AP. Costa RM. Silva AJ. 2001 Inducible, pharmacogenetic approaches to the study of learning and memory NatNeurosci 4 1238 1243
47. Ohno M. Sametsky EA. Younkin LH. Oakley H. Younkin SG. Citron M. Vassar R. Disterhoft JF. 2004 BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer's disease Neuron 41 27 33
48. Ohno M. Tseng W. Silva AJ. Disterhoft JF. 2005 Trace eyeblink conditioning requires the hippocampus but not autophosphorylation of αCaMKII in mice LearnMem 12 211 215
49. Saura CA. Chen G. Malkani S. Choi SY. Takahashi RH. Zhang D. Gouras GK. Kirkwood A. Morris RGM. Shen J. 2005 Conditional inactivation of presenilin 1 prevents amyloid accumulation and temporarily rescues contextual and spatial working memory impairments in amyloid precursor protein transgenic mice JNeurosci 25 6755 6764
50. Selkoe DJ. 2002 Alzheimer's disease is a synaptic failure Science 298 789 791
51. Selkoe DJ. Schenk D. 2003 Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics AnnuRevPharmacolToxicol 43 545 584
52. Singer O. Marr RA. Rockenstein EM. Crews L. Coufal NG. Gage FH. Verma IM. Masliah E. 2005 Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model NatNeurosci 8 1343 1349
53. Tang J. Ghosh AK. Hong L. Koelsch G. Turner RT. Chang W. 2003 Study of memapsin 2 (β-secretase) and strategy of inhibitor design JMolNeurosci 20 299 304
54. Tsien JZ. Huerta PT. Tonegawa S. 1996 The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory Cell 87 1327 1338
55. Turner PR. O'Connor K. Tate WP. Abraham WC. 2003 Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory ProgNeurobiol 70 1 32
56. Vassar R. Citron M. 2000 Aβ-generating enzymes: recent advances in β- and γ-secretase research Neuron 27 419 422
57. Vassar RJ. Oakley H. Krishnamurthy S. Maus E. Shao P. Guillozet A. Ohno M. Disterhoft J. Berry R. 2005 5XFAD Tg mice that express five FAD mutations have high-cerebral Aβ42 levels, rapid amyloid deposition, and intraneuronal Aβ SocNeurosciAbstr 587.2
58. Walsh DM. Klyubin I. Fadeeva JV. Cullen WK. Anwyl R. Wolfe MS. Rowan MJ. Selkoe DJ. 2002 Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo Nature 416 535 539
59. Walsh DM. Selkoe DJ. 2004 Deciphering the molecular basis of memory failure in Alzheimer's disease Neuron 44 181 193
60. Wong PC. Cai H. Borchelt DR. Price DL. 2002 Genetically engineered mouse models of neurodegenerative diseases NatNeurosci 5 633 639
61. Wong HK. Sakurai T. Oyama F. Kaneko K. Wada K. Miyazaki H. Kurosawa M. De Strooper B. Saftig P. Nukina N. 2005 β Subunits of voltage-gated sodium channels are novel substrates of β-site amyloid precursor protein-cleaving enzyme (BACE1) and γ-secretase JBiolChem 280 23009 23017
62. Yu H. Saura CA. Choi SY. Sun LD. Yang X. Handler M. Kawarabayashi T. Younkin L. Fedeles B. Wilson MA. Younkin S. Kandel ER. Kirkwood A. Shen J. 2001 APP processing and synaptic plasticity in presenilin-1 conditional knockout mice Neuron 31 713 726